Minocyline HCI

Displays antiapoptotic, anti-inflammatory 1 activity. Prevents neuropathic pain in a rat sciatic nerve injury model 1. Reduces MMP-9 activity 2. Attenuates disease severity in mouse models of multiple sclerosis 3. Displays neuroprotective activity 4. May be effective in methotrexate-induced lung fibrosis 5. Orally active and brain penetrant.

Catalog ID: N-3013

$76.00 – $304.00

Download Datasheet

  • Product Details
    • Physical State: Yellow powder
    • Temperature Storage: -20°C
    • Temperature Shipping: Ambient
    • Molecular Mass: 493.9

  • References

    1. Padi, S.S., and Kulkarni, S.K., (2008) Eur. J. Pharmacol., 601 : 79
    2. Dziembowska, M., et al., (2013) Am. J. Med. Genet. A, 161A : 1897
    3. Brundula, V., et al., (2002) Brain, 125 : 1297
    4. Tikka, T., et al., (2001) J. Neurosci., 21 : 2580
    5. Kalemci, S., et al., (2013) Eur. Rev. Med. Pharmacol. Sci., 17 : 3334

Related products